Enno Spillner
Director of Finance/CFO at FORMYCON AG
Net worth: 807 244 $ as of 2024-03-30
Profile
Presently, Enno Spillner holds the position of Chief Financial Officer for Evotec SE and Co-Managing Director at Evotec International GmbH (a subsidiary of Evotec SE). He is also on the board of Nanobiotix SA and Concentro Management AG and Managing Partner at Biom Venture Capital GmbH & Co. Fonds KG. In his past career Mr. Spillner occupied the position of Chief Executive & Financial Officer of 4SC AG, Managing Director at Munich Innovative Biomaterials GmbH, Managing Director at ActiPac Biosystems GmbH and Head-Finance & Controlling at BioM AG Munich BioTech Development. Enno Spillner received an MBA from the University of Bamberg.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
EVOTEC SE
0.03% | 2022-12-30 | 51,655 ( 0.03% ) | 807 244 $ | 2024-03-30 |
Enno Spillner active positions
Companies | Position | Start |
---|---|---|
NANOBIOTIX | Director/Board Member | 2014-06-17 |
FORMYCON AG | Director of Finance/CFO | 2023-03-31 |
Concentro Management AG
Concentro Management AG Investment ManagersFinance Concentro Management AG is a German company that offers services in corporate development and management. The private company is based in Munich, Germany. The company has offices in Munich, Leipzig, and Stuttgart. The company has supported various insolvency administrators in successful asset transfers and sales of companies. The company has also helped in the age-related succession plan of a shareholder of Ropro Produktions GmbH. Additionally, Concentro Management has increased EBIT and transparency in the group through a comprehensive restructuring program. | Director/Board Member | 2010-05-10 |
Biom Venture Capital GmbH & Co. Fonds KG
Biom Venture Capital GmbH & Co. Fonds KG Investment ManagersFinance Biom Venture Capital GmbH & Co. Fonds KG invests in early-stage companies based in the region of Bavaria in Germany focused on life sciences. | Corporate Officer/Principal | 2001-08-31 |
leon-nanodrugs GmbH
leon-nanodrugs GmbH Pharmaceuticals: MajorHealth Technology leon-nanodrugs GmbH develops oral and parenteral drugs. The firm's services include nanotechnology in medicine, MJR technology, pipeline, partnering with leon and leon network. The company was founded by Wolfgang Beier and Cornelia Beier in 2011 and is headquartered in Munich, Germany. | Director/Board Member | - |
Euronext Paris SA
Euronext Paris SA Investment Banks/BrokersFinance Euronext Paris SA operates as a stock exchange which provides solutions for regulated stock and derivatives markets in France. Its services include facilitating public offerings, providing trading facilities for cash and derivatives products, and supplying market data. The company was founded on January 20, 1988 and is headquartered in Courbevoie, France. | Director/Board Member | 2013-12-31 |
Former positions of Enno Spillner
Companies | Position | End |
---|---|---|
EVOTEC SE | Director of Finance/CFO | 2023-02-28 |
4SC AG | Chief Executive Officer | 2016-06-29 |
ActiPac Biosystems GmbH | Chief Executive Officer | 2000-02-29 |
░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - |
░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - |
Training of Enno Spillner
University of Bamberg | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 4 |
---|---|
4SC AG | Health Technology |
EVOTEC SE | Health Technology |
NANOBIOTIX | Health Technology |
FORMYCON AG | Health Technology |
Private companies | 8 |
---|---|
Evotec International GmbH
Evotec International GmbH Miscellaneous Commercial ServicesCommercial Services Evotec International GmbH develops and provides drugs for the treatment of CNS disorders. It focuses on Alzheimer's disease and other neurological disorders. The company was founded in 1999 and is headquartered in Hamburg, Germany. | Commercial Services |
Euronext Paris SA
Euronext Paris SA Investment Banks/BrokersFinance Euronext Paris SA operates as a stock exchange which provides solutions for regulated stock and derivatives markets in France. Its services include facilitating public offerings, providing trading facilities for cash and derivatives products, and supplying market data. The company was founded on January 20, 1988 and is headquartered in Courbevoie, France. | Finance |
BioM AG Munich BioTech Development
BioM AG Munich BioTech Development Investment ManagersFinance BioM AG Munich BioTech Development (BMBD) is a venture capital firm specialized in the life sciences sector. Located in Martinsried on the outskirts of Munich, BMBD was established in 2002 to manage the investment portfolio of BioM AG, a regional technology transfer and venture capital services company. BioM was created in 1997 following Munich's selection in the Government-sponsored BioRegio Competition, and provides business support services to Munich-based biotechnology companies, focusing on start-ups. BMBD manages the BioM Venture Capital fund. Their clients include regional banks, German and European private equity firms and private individuals. The firm operates in partnership with public entities, in particular the German Federal Ministry of Education and Research (BMBF) and HighTech Gründerfonds (HTGF), a partnership between the Government of Germany, the KfW banking group and leading technology corporations. | Finance |
Biom Venture Capital GmbH & Co. Fonds KG
Biom Venture Capital GmbH & Co. Fonds KG Investment ManagersFinance Biom Venture Capital GmbH & Co. Fonds KG invests in early-stage companies based in the region of Bavaria in Germany focused on life sciences. | Finance |
Concentro Management AG
Concentro Management AG Investment ManagersFinance Concentro Management AG is a German company that offers services in corporate development and management. The private company is based in Munich, Germany. The company has offices in Munich, Leipzig, and Stuttgart. The company has supported various insolvency administrators in successful asset transfers and sales of companies. The company has also helped in the age-related succession plan of a shareholder of Ropro Produktions GmbH. Additionally, Concentro Management has increased EBIT and transparency in the group through a comprehensive restructuring program. | Finance |
leon-nanodrugs GmbH
leon-nanodrugs GmbH Pharmaceuticals: MajorHealth Technology leon-nanodrugs GmbH develops oral and parenteral drugs. The firm's services include nanotechnology in medicine, MJR technology, pipeline, partnering with leon and leon network. The company was founded by Wolfgang Beier and Cornelia Beier in 2011 and is headquartered in Munich, Germany. | Health Technology |
ActiPac Biosystems GmbH | |
Munich Innovative Biomaterials GmbH
Munich Innovative Biomaterials GmbH Investment ManagersFinance Munich Innovative Biomaterials GmbH functions as a pension/retirement fund. The private company is based in Munich, Germany. | Finance |
- Stock Market
- Insiders
- Enno Spillner